2026

Professor Michelangelo Campanella awarded prestigious European Research Council funding to accelerate safer drug discovery
1 July 2026

Professor Michelangelo Campanella, Professor of Pharmacology and Director of Research at the William Harvey Research Institute, has been awarded a prestigious European Research Council (ERC) Proof of Concept Grant to accelerate the translation of his research into a technology that could improve the safety and efficiency of drug development.

William Harvey Research Institute celebrates 40 years of research excellence
30 June 2026

The William Harvey Research Institute (WHRI) at Queen Mary University of London marked its 40th anniversary with a two-day conference celebrating four decades of excellence in cardiovascular, endocrine and inflammation research, alongside its longstanding commitment to education and training the next generation of scientists and clinicians.

Psychological support service shown to improve staff wellbeing and reduce stress
29 June 2026

A new study has found that a psychological support service is helping staff at Barts Health NHS Trust feel better, cope better, and remain in their roles.

New AI heart failure screening tool could save lives, cut hospital waiting lists and deliver major NHS cost savings
11 June 2026

Scientists at Queen Mary University of London and Barts Health NHS Trust have been awarded £1.3m to develop the invention for use in the NHS.

Dr Suzanne Eldridge shortlisted for top business award
1 June 2026

The nomination signals the growing importance of high-value science-led innovation within British entrepreneurship.

 

Queen Mary researchers lead report on avoidable inequalities in cardiovascular disease burden and care
22 May 2026

Researchers from the William Harvey Research Institute at Queen Mary University of London have led a major new report revealing the continuing and unequal burden of cardiovascular disease (CVD) across Europe.

Drug that targets immune cells shows potential as new treatment for diabetic heart disease
27 February 2026

Researchers from Queen Mary University of London have found that a medication originally developed for glycemic control can reverse serious heart damage — not by controlling blood sugar as originally intended, but by retraining the immune system to protect the heart from within.

High-risk patients account for 80% of post-surgery deaths
25 February 2026

Large UK-wide study shows that high-risk patients account for nearly 80% of post-surgery deaths, highlighting the need for open conversations and more tailored care.